Market Overview:
The global HEPES market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for HEPES in cell culture and protein extraction applications. Additionally, rising research and development expenditure by pharmaceutical and biotechnology companies is also propelling the growth of the global HEPES market. However, stringent regulatory norms for drug approvals are restraining the growth of this market to some extent.
Product Definition:
A salt that is used to keep cells alive in a laboratory dish. It is important because it helps to maintain the right balance of acid and base in the cells' environment.
Crystalline Powder:
Crystalline powder is a solid form of salts which are made up of individual crystals. It has wide applications in the chemical industry and finds major use in pH control, deionization, evaporation processes and as an electrolyte. Crystalline powder is also used as a carrier for other chemicals or drugs by melting it down before adding to solutions that require cooling or heating purposes.
Buffering Agent:
A buffering agent is a substance that delays the reaction between two compounds by creating an environment that is more stable. The most common example of such agents are salts and alkalis used in pH buffers. Buffering agents can also be organic acids or bases, for instance, lactic acid helps to maintain the pH levels in muscle cells and blood; while bicarbonate (HCO3) acts as an antacid to prevent stomach irritation.
Application Insights:
Protein extraction was the largest application segment in terms of revenue and is expected to witness a CAGR of XX% from 2018 to 2030. The growth can be attributed to increasing demand for protein isolation from various sources such as human blood, tissue culture, milk powder, egg white powder and other animal sources.
The others segment includes chemical synthesis and is estimated to witness volume growth at a CAGR of XX% over the forecast period owing to rising demand for HEPES salts in various applications including glass manufacturing, paper making.
Regional Analysis:
North America dominated the global market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the presence of major pharmaceutical and biopharmaceutical companies, which are engaged in R&D activities for new drug development and other therapeutic applications at high energy density phosphate compounds. Moreover, increasing government funding for research activities pertaining to hydration properties of drugs will further boost growth during the forecast period from 2018 to 2030.
Asia Pacific is expected to witness lucrative growth over the coming years owing to rising investments by leading pharmaceutical companies such as Gilead Sciences, FUJIFILM Diosynth Biotechnologies Corporation, Novartis AG., among others for product development and research purposes related to hydrophilic properties associated with hydroxyapatite-based products used across various industries including healthcare & life sciences (HLS).
Growth Factors:
- Increasing demand for biotechnology and pharmaceutical products
- Rising prevalence of chronic diseases
- Growing number of research and development activities in the life sciences sector
- Technological advancements in the field of biochemistry
- Rising awareness about health and hygiene among consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
HEPES Market Research Report
By Type
Crystalline Powder, Buffering Agent
By Application
Cell Culture, Protein Extraction, Others
By Companies
Merck KGaA, Formedium, Amresco, Thermo Fisher Scientific, Caisson, Lonza, Ge Healthcare, Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Tocris Bioscience, BioSpectra, Avantor, VWR International, Corning, Irvine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global HEPES Market Report Segments:
The global HEPES market is segmented on the basis of:
Types
Crystalline Powder, Buffering Agent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Culture, Protein Extraction, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Formedium
- Amresco
- Thermo Fisher Scientific
- Caisson
- Lonza
- Ge Healthcare
- Biological Industries
- Cayman Chemical
- SERVA Electrophoresis GmbH
- Tocris Bioscience
- BioSpectra
- Avantor
- VWR International
- Corning
- Irvine
Highlights of The HEPES Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Crystalline Powder
- Buffering Agent
- By Application:
- Cell Culture
- Protein Extraction
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HEPES Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HEPES is a common name for a molecule with the formula H3O4. It is an ionic compound, meaning that it consists of atoms of hydrogen and oxygen.
Some of the key players operating in the hepes market are Merck KGaA, Formedium, Amresco, Thermo Fisher Scientific, Caisson, Lonza, Ge Healthcare, Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Tocris Bioscience, BioSpectra, Avantor, VWR International, Corning, Irvine.
The hepes market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. HEPES Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. HEPES Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. HEPES Market - Supply Chain
4.5. Global HEPES Market Forecast
4.5.1. HEPES Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. HEPES Market Size (000 Units) and Y-o-Y Growth
4.5.3. HEPES Market Absolute $ Opportunity
5. Global HEPES Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. HEPES Market Size and Volume Forecast by Type
5.3.1. Crystalline Powder
5.3.2. Buffering Agent
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global HEPES Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. HEPES Market Size and Volume Forecast by Application
6.3.1. Cell Culture
6.3.2. Protein Extraction
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global HEPES Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. HEPES Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global HEPES Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. HEPES Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global HEPES Demand Share Forecast, 2019-2029
9. North America HEPES Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America HEPES Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America HEPES Market Size and Volume Forecast by Application
9.4.1. Cell Culture
9.4.2. Protein Extraction
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America HEPES Market Size and Volume Forecast by Type
9.7.1. Crystalline Powder
9.7.2. Buffering Agent
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America HEPES Demand Share Forecast, 2019-2029
10. Latin America HEPES Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America HEPES Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America HEPES Market Size and Volume Forecast by Application
10.4.1. Cell Culture
10.4.2. Protein Extraction
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America HEPES Market Size and Volume Forecast by Type
10.7.1. Crystalline Powder
10.7.2. Buffering Agent
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America HEPES Demand Share Forecast, 2019-2029
11. Europe HEPES Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe HEPES Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe HEPES Market Size and Volume Forecast by Application
11.4.1. Cell Culture
11.4.2. Protein Extraction
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe HEPES Market Size and Volume Forecast by Type
11.7.1. Crystalline Powder
11.7.2. Buffering Agent
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Aplication
11.10.4. By Sales Channel
11.11. Europe HEPES Demand Share, 2019-2029
12. Asia Pacific HEPES Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific HEPES Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific HEPES Market Size and Volume Forecast by Application
12.4.1. Cell Culture
12.4.2. Protein Extraction
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific HEPES Market Size and Volume Forecast by Type
12.7.1. Crystalline Powder
12.7.2. Buffering Agent
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific HEPES Demand Share, 2019-2029
13. Middle East & Africa HEPES Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa HEPES Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa HEPES Market Size and Volume Forecast by Application
13.4.1. Cell Culture
13.4.2. Protein Extraction
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa HEPES Market Size and Volume Forecast by Type
13.7.1. Crystalline Powder
13.7.2. Buffering Agent
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa HEPES Demand Share, 2019-2029
14. Competition Landscape
14.1. Global HEPES Market: Market Share Analysis
14.2. HEPES Distributors and Customers
14.3. HEPES Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck KGaA
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Formedium
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Amresco
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Caisson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lonza
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ge Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biological Industries
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cayman Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SERVA Electrophoresis GmbH
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Tocris Bioscience
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BioSpectra
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Avantor
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. VWR International
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Corning
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Irvine
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
